
Dalmia Bharat Limited Announces Investor Conference Call for Q1 FY27 Results
Dalmia Bharat Limited has scheduled an investors and analysts group conference call to discuss the Unaudited Standalone and Consolidated Financial Results of the company for the quarter ending June 30, 2026.The conference call is set to take place on Friday, July 24, 2026, at 04:30 P.M. (IST).
This event provides stakeholders with an opportunity to review the financial performance of Dalmia Bharat Limited for the specified quarter.
Interested parties are provided various dial-in details for the conference call, including primary and secondary numbers, along with international toll-free options covering several regions.
Key participation details include:
| Detail | Information |
|---|---|
| Event | Investors/Analysts Group Conference Call |
| Results Covered | Unaudited Standalone and Consolidated Financial Results (Quarter ended June 30, 2026) |
| Date | Friday, July 24, 2026 |
| Time | 04:30 P.M. (IST) |
| Primary Call Number | +91 22 6280 1536 |
| Secondary Call Number | +91 22 7115 8344 |
DALBHARAT Stock Price Movement
Dalmia Bharat Limited shares shed value on Friday, settling lower by 0.32% to close at ₹1823.2. The stock saw a traded volume of 342,265 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.